2
4
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Auer rods
Auer rods
Chronic lymphocytic leukemia - microscopic view
Chronic lymphocytic leukemia - microscopic view
Antibodies
Antibodies

Chronic lymphocytic leukemia (CLL)
Definition:
Chronic lymphocytic leukemia is a malignancy (cancer) of the white blood cells (lymphocytes) characterized by a slow, progressive increase of these cells in the blood and the bone marrow.

Alternative Names:
CLL

Causes, incidence, and risk factors:

Chronic lymphocytic leukemia (CLL) affects the B lymphocytes and causes immunosuppression, failure of the bone marrow and invasion of malignant (cancerous) cells into organs.

Usually the symptoms develop gradually. The incidence is about 2 per 100,000 and increases with age. 90% of cases are found in people over 50 years old. Many cases are detected by routine blood tests in people with no symptoms. The cause of CLL is unknown. No relationship to radiation, carcinogenic chemicals or viruses has been determined. The disease is more common in Jewish people of Russian or Eastern European descent and is uncommon in Asia.
Symptoms:
Signs and tests:
This disease may also alter the results of serum protein electrophoresis.
Treatment:

Early stage disease often requires no specific treatment (since early treatment does not improve survival), but close observation is important. Chemotherapy may be needed if a patient develops fatigue, anemia, thrombocytopenia or enlarged lymph nodes that are troublesome.

The anti-cancer medicine (chemotherapy) used first is usually fludarabine. Other medicines that may be used in this disease include chlorambucil (Leukeran) and cyclophosphamide (Cytoxan).

Recently, the drug alemtuzumab (Campath), which is an antibody against the surface of CLL cells, has been approved for treatment of patients with CLL who have failed fludarabine. Another antibody drug, rituximab (Rituxan), may also be used. Rarely, radiation may be used for enlarged lymph nodes. Blood transfusions or platelet transfusions may be required.
Support Groups:
The stress of illness can often be helped by joining a support group where members share common experiences and problems.
Expectations (prognosis):
The prognosis depends on the stage of the disease. Half of patients diagnosed in the earliest stages of the disease live more than 12 years. On the other hand, if CLL has reached an advanced stage, about half of patients die within 2 years.
Complications:
Calling your health care provider:
Call health care provider if you develop enlarged lymph nodes or unexplained fatigue, bruising, excessive sweating, or weight loss.
Review Date: 8/4/2002
Reviewed By: Scott Howard, M.D., M.S., Memphis, TN. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com